Acadia Healthcare Company, Inc. ACHC
28.09
0.29
1.04%
as of 25 Sep
- Market cap
- $2.6B
- P/E
- 0.0×
Follow ACHC
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 20.98 |
+8 more quarters Free account |
P/S ratio |
0.80 | 0.63 | 0.39 | 0.69 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
16.55 | 34.41 | (14.92) | 30.58 | |
P/B ratio |
1.36 | 1.08 | 0.66 | 0.72 | |
Price to Tangible BV |
4.66 | 3.79 | 2.32 | 2.99 | |
EV/Sales |
1.46 | 1.33 | 1.10 | 1.36 | |
EV/EBITDA |
9.12 | 7.56 | 6.28 | 7.02 | |
EV/Operating CF |
23.40 | 24.65 | 27.70 | 13.23 | |
EV/FCF |
(49.10) | (17.83) | (8.78) | (13.68) | |
Quick Ratio |
1.19 | 1.29 | 1.09 | 1.06 | |
Current Ratio |
1.57 | 1.71 | 1.55 | 1.44 | |
Net Debt/EBITDA |
16.09 | 17.22 | 24.98 | 13.02 | |
Debt/Assets |
43.53% | 45.56% | 45.23% | 36.01% | |
Debt/Equity |
1.22 | 1.29 | 1.28 | 0.74 | |
Asset Turnover |
0.57 | 0.58 | 0.58 | 0.53 | |
Operating CF/Net income |
14.83 | 14.99 | 0.07 | 2.02 | |
Capex/Depreciation |
(0.55) | (1.12) | (1.96) | (2.66) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
64.68% | 66.33% | 65.73% | 63.89% | |
Intangible Assets out of Total Assets |
0.25 | 0.25 | 0.25 | 0.37 | |
Share Based Compensation of Revenue |
1.27% | 0.96% | 0.79% | 0.71% | |
Graham Net Nets |
(1.01) | (1.30) | (2.15) | (1.14) | |
Graham Number |
0.00 | 0.00 | 0.00 | 30.27 | |
Earnings Yield |
(42.16%) | (52.33%) | (85.98%) | 4.77% | |
Free Cash Flow Yield |
(3.74%) | (11.88%) | (32.33%) | (14.47%) | |
Revenue per Share |
9.53 | 9.16 | 9.06 | 9.42 | |
Operating CF per Share |
1.78 | 0.68 | (0.95) | 0.81 | |
Capex per Share |
(0.31) | (0.66) | (1.02) | (1.43) | |
Free Cash Flow per Share |
1.47 | 0.01 | (1.97) | (0.62) | |
Cash per Share |
1.89 | 1.75 | 1.47 | 1.31 | |
Shareholders Equity per Share |
21.79 | 21.63 | 21.49 | 34.51 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.79 | 21.63 | 21.49 | 34.51 | |
Free Cash Flow |
133.63 | 1.35 | (178.79) | (56.50) | |
Working Capital |
307.71 | 347.84 | 288.95 | 230.03 | |
Capital Expenditures |
(28.44) | (60.18) | (92.49) | (129.71) | |
Net Current Asset Value |
(2,721.92) | (2,750.98) | (2,764.35) | (2,544.49) | |
EV/EBIT |
14.54 | 11.41 | 9.42 | 9.98 | |
Capex to Sales |
0.03 | 0.07 | 0.11 | 0.15 | |
Net Profit Margin |
1.26% | 0.50% | (143.34%) | 4.26% | |
Price to Operating Income |
7.92 | 5.38 | 3.32 | 5.04 | |
| Other line items | |||||
Average Receivables |
439.65 | 434.19 | 402.97 | 407.39 | |
Average Payables |
177.54 | 173.11 | 191.55 | 190.66 | |
Average Assets |
5,927.34 | 5,847.02 | 5,742.18 | 6,141.60 | |
Average Common Equity |
2,528.55 | 2,499.92 | 2,511.34 | 3,075.91 |
Columns are period end dates